MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 3, 2004; DOI: 10.1124/mol.104.005314


0026-895X/05/6702-480-488$20.00
Mol Pharmacol 67:480-488, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.005314v1
67/2/480    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuk, S.
Right arrow Articles by Lotan, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuk, S.
Right arrow Articles by Lotan, I.
ORIGINAL ARTICLE

Kv2.1 Channel Activation and Inactivation Is Influenced by Physical Interactions of Both Syntaxin 1A and the Syntaxin 1A/Soluble N-Ethylmaleimide-Sensitive Factor-25 (t-SNARE) Complex with the C Terminus of the Channel

Sharon Tsuk, Izhak Michaelevski, Geoffrey N. Bentley, Rolf H. Joho, Dodo Chikvashvili, and Ilana Lotan

Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Israel (S.T., I.M., D.C., I.L.); School of Biology, University of Leeds, West Yorkshire, Leeds, United Kingdom (G.N.B.); and Center for Basic Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas (R.H.)

Abstract

Kv2.1, the prevalent delayed-rectifier K+ channel in neuroendocrine and endocrine cells, was suggested previously by our group to be modulated in islet {beta}-cells by syntaxin 1A (Syx) and soluble N-ethylmaleimide-sensitive factor attachment protein-25 (SNAP-25). We also demonstrated physical interactions in neuroendocrine cells between Kv2.1, Syx, and SNAP-25, characterized their effects on Kv2.1 activation and inactivation in Xenopus laevis oocytes, and suggested that they pertain to the assembly/disassembly of the Syx/SNAP-25 (t-SNARE) complex. In the present work, we established the existence of a causal relationship between the physical and the functional interactions of Syx with the Kv2.1 channel using three different peptides that compete with the channel for binding of Syx when injected into oocytes already coexpressing Syx with Kv2.1 in the plasma membrane: one peptide corresponding to the Syx-binding region on the N-type Ca2+ channel, and two peptides corresponding to Syx-binding regions on the Kv2.1 C terminus. All peptides reversed the effects of Syx on Kv2.1, suggesting that the hyperpolarizing shifts of the steady-state inactivation and activation of Kv2.1 caused by Syx result from cell-surface protein-protein interactions and point to participation of the C terminus in such an interaction. In line with these findings, the effects of Syx were dissipated by partial deletions of the C terminus. Furthermore, the t-SNARE complex was shown to bind to the Kv2.1 C terminus, and its effects on the inactivation of Kv2.1 were dissipated by partial deletions of the C terminus. Taken together, these findings suggest that physical interactions of both Syx and the t-SNARE complex with the C terminus of Kv2.1 are involved in channel regulation.


Received July 25, 2004; accepted October 27, 2004

Address correspondence to: Dr. Ilana Lotan, Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, 69978 Ramat-Aviv, Israel. E-mail: ilotan{at}post.tau.ac.il




This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. P. Mohapatra, D. F. Siino, and J. S. Trimmer
Interdomain Cytoplasmic Interactions Govern the Intracellular Trafficking, Gating, and Modulation of the Kv2.1 Channel
J. Neurosci., May 7, 2008; 28(19): 4982 - 4994.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, S. E. McKay, B. Bewley, and L. K. Kaczmarek
Repetitive Firing Triggers Clustering of Kv2.1 Potassium Channels in Aplysia Neurons
J. Biol. Chem., April 18, 2008; 283(16): 10632 - 10641.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Y. M. Leung, E. P. Kwan, B. Ng, Y. Kang, and H. Y. Gaisano
SNAREing Voltage-Gated K+ and ATP-Sensitive K+ Channels: Tuning {beta}-Cell Excitability with Syntaxin-1A and Other Exocytotic Proteins
Endocr. Rev., October 1, 2007; 28(6): 653 - 663.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. P. Mohapatra, H. Vacher, and J. S. Trimmer
The Surprising Catch of a Voltage-Gated Potassium Channel in a Neuronal SNARE
Sci. Signal., July 3, 2007; 2007(393): pe37 - pe37.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Singer-Lahat, A. Sheinin, D. Chikvashvili, S. Tsuk, D. Greitzer, R. Friedrich, L. Feinshreiber, U. Ashery, M. Benveniste, E. S. Levitan, et al.
K+ Channel Facilitation of Exocytosis by Dynamic Interaction with Syntaxin
J. Neurosci., February 14, 2007; 27(7): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
P. Campanoni and M. R. Blatt
Membrane trafficking and polar growth in root hairs and pollen tubes
J. Exp. Bot., January 1, 2007; 58(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Wolf-Goldberg, I. Michaelevski, L. Sheu, H. Y. Gaisano, D. Chikvashvili, and I. Lotan
Target Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptors (t-SNAREs) Differently Regulate Activation and Inactivation Gating of Kv2.2 and Kv2.1: Implications on Pancreatic Islet Cell Kv Channels
Mol. Pharmacol., September 1, 2006; 70(3): 818 - 828.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics